Weight-loss wonder pharmaceuticals Ozempic and Mounjaro may have a new rival to contend with as early as 2026, which is expected to have significantly fewer side effects—if not none at all.
The news follows various studies indicating that the use of GLP-1 medications has exceeded 700% since 2019. In fact, it has become so popular that nearly every celeb who loses weight sparks Ozempic rumors.
The upcoming offering has shown promise in lab tests and is set to undergo its first human trials.
